Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624
This examiner grants 83% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18446244 | INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION | Non-Final OA | The Johns Hopkins University |
| 18102141 | METHOD FOR PRODUCING FLUORINATED ETHER COMPOUND | Final Rejection | AGC INC. |
| 18002636 | HAIR CARE COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17794109 | METHOD FOR TREATMENT OF ACQUIRED COGNITIVE DEFICITS | Non-Final OA | CORNELL UNIVERSITY |
| 17904039 | POLYACRYLATE-FREE COSMETIC PREPARATION | Non-Final OA | BEIERSDORF AG |
| 18574167 | CANNABIDIOLIC ACID ESTERS FOR TREATING PRADER-WILLI SYNDROME | Non-Final OA | Yissum Res Dev Co of Hebrew Uni of Jerusalem Ltd. |
| 18024623 | RHO KINASE INHIBITION FOR TREATMENT OF PROLIFERATIVE VITREORETINOPATHY AND CONDITIONS ASSOCIATED WITH EPITHELIAL TO MESENCHYMAL TRANSITION | Non-Final OA | The Schepens Eye Research Institute, Inc. |
| 18209437 | PYRROLINONE COMPOUND AND METHOD FOR PREPARING THE SAME | Non-Final OA | WUHAN JIANMIN DAPENG PHARMACEUTICAL CO., LTD. |
| 17311784 | A VILAZODONE SOLID DISPERSION AND PREPARATION METHOD THEREOF | Final Rejection | SUNSHINE LAKE PHARMA CO., LTD. |
| 18052505 | LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Non-Final OA | Arcturus Therapeutics, Inc. |
| 17997056 | COMPOSITION FOR REDUCING HEPATIC TRIGLYCERIDES AND/OR IMPROVING GLUCOSE METABOLISM | Non-Final OA | Universite Laval |
| 17967344 | NOVEL QUINAZOLINONES THAT INHIBIT THE FORMATION OF TAU OLIGOMERS AND THEIR METHOD OF USE | Non-Final OA | OLIGOMERIX INC. |
| 17908200 | LIGHT-ACTIVATED PATHOGEN-KILLING MOLECULES AND USES THEREOF | Non-Final OA | UNIVERSITY INDUSTRY PARTNERSHIPS (UIP) |
| 17802651 | Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and pharmaceutical compositions thereof | Non-Final OA | AIC246 AG & Co. KG |
| 17759232 | CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF | Non-Final OA | JIANGSU HENGRUI MEDICINE CO., LTD. |
| 17866672 | QUINOXALINE DERIVATIVES | Non-Final OA | GRUENENTHAL GMBH |
| 17270665 | NOVEL BISARYLETHER COMPOUNDS | Non-Final OA | XENIOPRO GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy